Medical College of Wisconsin
CTSIResearch InformaticsREDCap

The Role of Radiofrequency Ablation in Benign and Malignant Thyroid Nodules. Surg Clin North Am 2024 Aug;104(4):779-789

Date

06/30/2024

Pubmed ID

38944498

DOI

10.1016/j.suc.2024.02.007

Scopus ID

2-s2.0-85188679006 (requires institutional sign-in at Scopus site)   6 Citations

Abstract

Radiofrequency ablation (RFA) offers a minimally invasive solution for benign, autonomously functioning (AFTN), and malignant thyroid nodules. The technique utilizes high-frequency alternating current to induce coagulative necrosis, effectively destroying target tissue. RFA is performed in the outpatient setting with local anesthesia and sonographic guidance. RFA is effective in producing substantial volume reduction rates in benign nodules and is emerging as a favorable option in AFTN and papillary thyroid microcarcinoma. RFA's advantages include lower complication rates, minimal scarring, and improved quality-of-life outcomes compared to surgery. However, its efficacy in larger and recurrent malignancies requires further investigation.

Author List

Shah M, McManus C

Author

Catherine McManus MD, MS Associate Professor in the Surgery department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Humans
Thyroid Neoplasms
Thyroid Nodule
Treatment Outcome